RxDoctor Payments Data

Ignacio Valdes, MD

Psychiatry · Houston, TXNPI 1760546360

Payments from drug & device makers

$218,298in general payments, 2019–2025

Across 1,552 payments — averaging $140.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$94K
  • Teva Pharmaceuticals USA, Inc.$51K
  • Neurocrine Biosciences, Inc.$26K
  • Otsuka America Pharmaceutical, Inc.$19K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$10K
  • Alkermes, Inc.$2K
  • plus $16K from 32 others

What the payments were for

  • Consulting fees$9,6748%
  • Speaking & faculty fees$77,06167%
  • Travel & lodging$1,3381%
  • Food & beverage$26,34623%
  • Education$1350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$218,298 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$340,644
Medicare patients
243
Services billed
4,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate285$866,220
IngrezzaValbenazine Tosylate71$563,015
AustedoDeutetrabenazine42$195,685
Abilify MaintenaAripiprazole66$182,904
RexultiBrexpiprazole97$163,764
LybalviOlanzapine/Samidorphan Malate74$120,381
Invega TrinzaPaliperidone Palmitate12$97,480
AristadaAripiprazole Lauroxil33$93,656
PerserisRisperidone29$81,928
FanaptIloperidone24$43,419
Adderall XrDextroamphetamine/Amphetamine100$39,537
Lurasidone Hcl136$33,653
AuvelityDextromethorphan Hbr/Bupropion34$21,214
SecuadoAsenapine15$20,849
Varenicline Tartrate87$20,709

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$1,699$963,701297 claims
Neurocrine Biosciences, Inc.Ingrezza$26,439$563,01571 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$19,477$346,668163 claims
Alkermes, Inc.Lybalvi, Aristada$2,454$214,036107 claims
Teva Pharmaceuticals USA, Inc.Austedo$50,646$195,68542 claims
Indivior Inc.Perseris, Suboxone$1,120$91,74643 claims
Vanda Pharmaceuticals Inc.Fanapt$1,318$43,41924 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$787$29,17965 claims
Axsome Therapeutics, Inc.Auvelity$236$21,21434 claims
Noven Pharmaceuticals, Inc.Secuado$1,836$20,84915 claims
AbbVieVraylar$159$20,69615 claims
MerckBelsomra$131$9,73822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →